Cyclopropylmethyl (12aS)-8-chloro-9-oxo-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate is a complex organic compound characterized by its unique bicyclic structure, which incorporates both imidazole and benzodiazepine moieties. This compound features a cyclopropylmethyl group, contributing to its potential biological activity and interaction with various biological targets. The presence of a chloro substituent and a carbonyl group (oxo) suggests reactivity that may be relevant in medicinal chemistry, particularly in the development of pharmaceuticals. The compound's structure indicates it may exhibit properties such as sedative, anxiolytic, or anticonvulsant effects, typical of benzodiazepine derivatives. Its specific stereochemistry, denoted by the (12aS) configuration, may influence its pharmacological profile and interactions with receptors. As with many compounds in this class, understanding its solubility, stability, and metabolic pathways is crucial for assessing its potential therapeutic applications and safety profile. Further studies would be necessary to elucidate its full biological activity and mechanism of action.

cyclopropylmethyl (12aS)-8-chloro-9-oxo-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate

90450-01-4: Cyclopropylmethyl (12aS)-8-chloro-9-oxo-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate is a complex organic compound characterized by its unique bicyclic structure, which incorporates both imidazole and benzodiazepine moieties. This compound features a cyclopropylmethyl group, contributing to its potential biological activity and interaction with various biological targets. The presence of a chloro substituent and a carbonyl group (oxo) suggests reactivity that may be relevant in medicinal chemistry, particularly in the development of pharmaceuticals. The compound's structure indicates it may exhibit properties such as sedative, anxiolytic, or anticonvulsant effects, typical of benzodiazepine derivatives. Its specific stereochemistry, denoted by the (12aS) configuration, may influence its pharmacological profile and interactions with receptors. As with many compounds in this class, understanding its solubility, stability, and metabolic pathways is crucial for assessing its potential therapeutic applications and safety profile. Further studies would be necessary to elucidate its full biological activity and mechanism of action.

<p>Ro 17-1812 is a partial agonist of benzodiazepine receptor.</p>

CAS 90450-01-4

cyclopropylmethyl (12aS)-8-chloro-9-oxo-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate

Ro 17-1812

Ref: TM-T28561